Changes in the burden of malaria in sub-Saharan Africa, Lancet Infect Dis, vol.10, issue.10, pp.70096-70103, 2010. ,
, World Health Organization. World malaria report, 2016.
Artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.361, pp.455-67, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-02427334
Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance, Clin Infect Dis, vol.53, pp.224-254, 2011. ,
Improved diagnostic testing and malaria treatment practices in Zambia, JAMA, vol.297, pp.2227-2258, 2007. ,
,
, Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium. Evidence of artemisinin-resistant malaria in western Cambodia, N Engl J Med, vol.359, pp.2619-2639, 2008.
, World Health Organization. Artemisinin and artemisinin-based combination therapy resistance. Status report, p.2017, 2017.
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, vol.505, pp.50-55, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00921203
Spread of artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.371, pp.411-434, 2014. ,
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study, Lancet Infect Dis, vol.17, issue.16, pp.30415-30422, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01400955
Genetic markers associated with dihydroartemisininpiperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study, Lancet Infect Dis, vol.17, issue.16, pp.30409-30410, 2017. ,
A variant PfCRT isoform can contribute to Plasmodium falciparum resistance to the first-line partner drug piperaquine, MBio, vol.8, pp.303-320, 2017. ,
Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin, J Infect Dis, vol.194, pp.528-563, 2006. ,
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number, Lancet, vol.364, pp.16767-16773, 2004. ,
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia ,
, Malar J, vol.8, p.11, 2009.
The pfmdr1 gene is associated with a multidrugresistant phenotype in Plasmodium falciparum from the western border of Thailand, Antimicrob Agents Chemother, vol.43, pp.2943-2952, 1999. ,
Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand, Mol Biochem Parasitol, vol.57, pp.151-60, 1993. ,
Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies, Expert Rev Anti Infect Ther, vol.15, pp.527-570, 2017. ,
Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania, Malar J, vol.11, p.58, 2012. ,
Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic, Antimicrob Agents Chemother, vol.50, pp.1893-1898, 2006. ,
Contribution of the pfmdr1 gene to antimalarial drug-resistance, Acta Trop, vol.94, pp.181-90, 2005. ,
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance, Mol Cell, vol.6, pp.861-71, 2000. ,
In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria, Acta Trop, vol.120, pp.224-254, 2011. ,
Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine, Proc Natl Acad Sci U S A, vol.106, pp.18883-18892, 2009. ,
In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa, J Infect Dis, vol.199, pp.750-757, 2009. ,
Genetic architecture of artemisinin-resistant Plasmodium falciparum, Nat Genet, vol.47, pp.226-260, 2015. ,
Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria, J Infect Dis, vol.185, pp.380-388, 2002. ,
, Policy recommendation on intermittent preventive treatment during infancy with sulfadoxinepyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa. Geneva: The Organization, pp.1-3
Drug-resistant malaria: molecular mechanisms and implications for public health, FEBS Lett, vol.585, pp.1551-62, 2011. ,
Intensity of malaria transmission and the evolution of drug resistance, Acta Trop, vol.94, pp.218-247, 2005. ,
How malaria has affected the human genome and what human genetics can teach us about malaria, Am J Hum Genet, vol.77, pp.171-92, 2005. ,
Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort, Proc Natl Acad Sci U S A, vol.114, pp.3515-3535, 2017. ,
Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulfadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique, Malar J, vol.7, p.115, 2008. ,
Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out, PLoS One, vol.6, issue.25992, 2011. ,
In-vivo efficacy of chloroquine to clear asymptomatic infections in Mozambican adults: a randomized, placebo-controlled trial with implications for elimination strategies, Sci Rep, vol.7, p.1356, 2017. ,
Sub-microscopic infections and long-term recrudescence of Plasmodium falciparum in Mozambican pregnant women ,
, Malar J, vol.8, issue.9, 2009.
A quality control program within a clinical trial consortium for PCR protocols to detect Plasmodium species, J Clin Microbiol, vol.52, pp.2144-2153, 2014. ,
A worldwide map of Plasmodium falciparum K13-propeller polymorphisms, N Engl J Med, vol.374, pp.2453-64, 2016. ,
Efficacy and safety of artemetherlumefantrine for the treatment of uncomplicated falciparum malaria at sentinel sites in Mozambique, Acta Trop, vol.171, pp.146-50, 2015. ,
, Emerging Infectious Diseases ? www.cdc.gov/eid ?, vol.24, issue.1, 2018.
K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa, J Infect Dis, vol.211, pp.1352-1357, 2015. ,
Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility, Antimicrob Agents Chemother, vol.53, pp.4588-97, 2009. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00741124
Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment, Antimicrob Agents Chemother, vol.59, pp.4719-4745, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02560651
Treatment failure of dihydroartemisinin/ piperaquine for Plasmodium falciparum malaria, Vietnam. Emerg Infect Dis, vol.23, pp.715-722, 2017. ,
Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia, Trop Med Int Health, vol.11, pp.1360-1366, 2006. ,
Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, Antimicrob Agents Chemother, vol.57, pp.686-698, 2008. ,
Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study, Lancet Infect Dis, vol.16, pp.487-496, 2016. ,
Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand, Malar J, vol.15, p.519, 2016. ,
Polymorphisms in Plasmodium falciparum K13-propeller in Angola and Mozambique after the introduction of the ACTs, PLoS One, vol.10, p.119215, 2015. ,
, World Health Organization. Status report on artemisinin and ACT resistance, 2015.
Novel mutations in K13 propeller gene of artemisininresistant Plasmodium falciparum, Emerg Infect Dis, vol.21, pp.490-492, 2015. ,